Neuphoria Therapeutics (NEUP) Return on Assets [ROA] (2024 - 2026)
Neuphoria Therapeutics' Return on Assets [ROA] was -42.36% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 41.11 percentage points from -1.25% a year earlier but up 6.47 percentage points from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Return on Assets [ROA] (2024 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Return on Assets [ROA] at Neuphoria Therapeutics came in at -46.95%, down 45.64 percentage points from FY2025.
- Return on Assets [ROA] shows a five-year change of -15.45 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Assets [ROA] was -1.31% in FY2025 (+53.81 pp), -55.12% in FY2024 (+1.38 pp), -56.50% in FY2023 (-21.31 pp) and -35.20% in FY2022 (-3.69 pp).
- Quarterly Return on Assets [ROA] has moved between -48.82% (fiscal Q3 2026) and 23.84% (fiscal Q3 2025) over five years.
- Compared with a year earlier, Return on Assets [ROA] was higher in two of the last four quarters, with an average year-over-year change of -20.64 percentage points.
- Per Business Quant data, NEUP's Return on Assets [ROA] in the three fiscal quarters before Q4 2026 was -48.82% (Q3 2026), -17.72% (Q2 2026) and -33.87% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Neuphoria Therapeutics | 335.34 Mn | 260.15 Mn | - | -39.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -39.89% |
| Mar 31, 2026 | -43.65% |
| Dec 31, 2025 | -13.05% |
| Sep 30, 2025 | -35.18% |
| Jun 30, 2025 | -0.68% |
| Mar 31, 2025 | 20.16% |
| Dec 31, 2024 | -43.40% |
| Sep 30, 2024 | -38.71% |
API Access
Neuphoria Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();